The NMDA (N-methyl-d-aspartate) receptor transduces the binding of glutamate and glycine, coupling it to the opening of a calciumpermeable ion channel 1 . Owing to the lack of high-resolution structural studies of the NMDA receptor, the mechanism by which ion-channel blockers occlude ion permeation is not well understood. Here we show that removal of the amino-terminal domains from the GluN1-GluN2B NMDA receptor yields a functional receptor and crystals with good diffraction properties, allowing us to map the binding site of the NMDA receptor blocker, MK-801. This crystal structure, together with long-timescale molecular dynamics simulations, shows how MK-801 and memantine (a drug approved for the treatment of Alzheimer's disease) bind within the vestibule of the ion channel, promote closure of the ion channel gate and lodge between the M3-helix-bundle crossing and the M2-pore loops, physically blocking ion permeation.
. Activation of the ion channel requires binding of glutamate and glycine as well as voltage-dependent relief of magnesium block 5, 6 ; these cause membrane depolarization and calcium influx 7 , both of which are critical for synaptic transmission and plasticity, and in cellular mechanisms of learning and memory 8 . Neurodegenerative disorders, chronic pain, stroke and schizophrenia have all been attributed to the dysfunction of NMDA receptors 9 . Over-activation of NMDA receptors is excitotoxic and contributes to neuronal damage after stroke or traumatic injury 10 . Furthermore, chronic NMDA receptor hyperactivity gives rise to the loss of neurons associated with Huntington's, Parkinson's and Alzheimer's diseases 11 . The ATDs are central to subunit-specific receptor assembly, to the probability, duration and deactivation rate of channel opening 12 , and to the binding of allosteric modulators such as ifenprodil and Ro 25-698 13 , which inhibit GluN1-GluN2B NMDA receptors and show promise for the treatment of Parkinson's and Alzheimer's diseases 14 . pH-dependent GluN2B-selective inhibitors are neuroprotective in traumatic brain injury, suggesting a strategy for treating brain injury with minimal side effects 15 . Moreover, small molecules that target the TMD, including MK-801 (dizocilpine) and memantine, show promise for the treatment of excitotoxicity-related disorders 16 . MK-801 is a neuroprotective agent in animal models of stroke, trauma and Parkinsonism but it can induce psychotic behaviour and neuronal degeneration 17 . The side effects of MK-801, which are probably a result of its high affinity for and long dwell time on the receptor, preclude its clinical application. By contrast, memantine, which binds more weakly to the ion channel, is well tolerated in clinical use. Memantine is used to treat Alzheimer's disease and early-onset epileptic encephalopathy 18, 19 . Here we combine crystallography with long-timescale molecular dynamics simulations to show how the GluN1-GluN2B NMDA receptor is blocked by MK-801 and memantine.
To facilitate structural analysis, we expressed GluN1-GluN2B NMDA receptor subunits 3 lacking the ATD, yielding the ∆ATD receptor (Extended Data Fig. 1a, b) , which was crystallized with glycine, glutamate and MK-801 (Fig. 1a, b) . The ∆ATD receptor crystallizes with two receptor complexes in the crystallographic asymmetric unit and, although each complex has a similar overall structure, there are differences in the relative positions of the LBD and TMD layers owing to the flexible nature of the LBD-TMD linkers ( Fig. 1c-f , Extended Data Fig. 1c ). The LBD layer adopts a 'dimer of dimers' organization, maintaining the same intra-dimer interface found in the intact GluN1-GluN2B NMDA receptor (the ∆2 receptor) 3 . In this ∆ATD receptor structure, however, the LBD subunits have swapped partners relative to their arrangement in the ∆2 receptor (Fig. 1e, f) , thus relaxing the GluN2B LBD-TMD linkers and precluding them from transmitting conformational changes of the LBD to the TMD 20 (Extended Data Fig. 2a-d , Supplementary Video 1). Double electron-electron resonance (DEER) experiments show that the LBD layer of the ∆ATD receptor in solution adopts two arrangements of the LBD subunits, one that is consistent with the intact ∆2 NMDA receptor 3 , and one that is consistent with that observed in the ∆ATD crystal structure (Extended Data Fig. 2e ). We hypothesize that, because a fraction of the ∆ATD receptor molecules populate an intact receptor-like LBD layer arrangement, the ∆ATD receptor retains agonist-induced ion channel gating. However, the ∆ATD receptor also populates a conformation with a subunit-swapped LBD layer, a putatively inactive conformation that preferentially forms crystals. The propensity of the ∆ATD receptor to adopt a LBD-swapped arrangement emphasizes the role of the ATD in defining the subunit arrangement of the LBD layer.
The ∆ATD receptor retains agonist-induced ion channel activity, demonstrating that the ion channel is gated by glycine and glutamate (Extended Data Fig. 3a) . Because the ∆ATD receptor contains the thermostabilizing mutation G610R within the TMD, the dissociation constant (K d ) for MK-801 of 1.6 ± 0.3 μM is higher than that of the intact receptor, which has a K d for MK-801 of 111.3 ± 8.5 nM (Fig. 2a) . Indeed, when the G610R substitution is introduced into the ∆2 receptor, the K d for MK-801 increases to 1.1 ± 0.4 μM, similar to that of the ∆ATD receptor (Fig. 2a) . To ensure MK-801 occupancy within the ∆ATD receptor TMD, we incubated the ∆ATD receptor with a saturating concentration of MK-801 before crystallization. Diffractionquality crystals emerged after two weeks and we solved the structure by molecular replacement (Extended Data Table 1 ).
The structure of the TMD of the ∆ATD NMDA receptor exhibits a similar 'closed-blocked' state and pore radius as that of the ∆2 receptor Letter reSeArCH electron density, we are now able to define the binding site of MK-801 (Fig. 2b) .
MK-801 resides within the channel vestibule and fits snugly in the binding pocket, with its nitrogen atom near N612 of GluN2B (Fig. 2c, d ). The omit electron density map showed only electron density for the β-carbon of N612; we therefore did not build the complete side chain. Nevertheless, we modelled the side chain and determined that there is space for the complete side chain and that the oxygen of the primary amide can be positioned to interact with the amino group of MK-801. The two aromatic rings of MK-801 are juxtaposed next to the M3 helix of the GluN1 subunit, close to the V642 residues, whereas the methyl substituent is near L640 on the M3 helix of GluN2B (Fig. 2c, d) . Accordingly, the substitutions V642A and V642L in GluN1, and L640A in GluN2B, extinguish MK-801 binding, consistent with previous studies 21 and with the importance of these residues for lining the binding pocket (Fig. 2e) .
There are two 'tunnels' near the M2 helices of the TMD structure that connect the central vestibule to the interior of the membrane bilayer (Fig. 2f) . The tunnels begin from the central vestibule and pass through cavities between the M2 and M3 helices of GluN1 and the adjacent M3 helices of GluN2B (Extended Data Fig. 4) . The radii of the two tunnels range from 1.3 to 2.9 Å and from 1.8 to 2.9 Å, respectively (Fig. 2f) , large enough to accommodate the aliphatic tails of lipids. Indeed, in our molecular dynamics simulations, the lipid tails transiently entered these tunnels (Extended Data Fig. 4) . We hypothesize that these tunnels could be transiently large enough to allow the diffusion of small molecules into the pore, perhaps explaining how small molecules are able to leave the closed, deactivated channel 22 . Nevertheless, our simulations find that both memantine and MK-801 enter the binding site of the open, activated, intact receptor via the aqueous path (Supplementary Videos 2-5).
The conformation of the ion channel region, consisting of the M2 helices, the pore loops and the M3 helices, differs between the GluN1 and GluN2B subunits (Fig. 3a) . Residing on the tips of the pore loops, the long-studied N-site asparagines 23, 24 , N614 (GluN1) and N612 (GluN2B), together with the N + 1 site asparagines, N613 (GluN2B), have marked effects on channel block by MK-801 21 because they project their side chains into the vestibule and interact with MK-801 (Fig. 3b, c) . These asparagines also contribute to the selectivity filter, modulating calcium permeability and voltage-dependent magnesium block 23, 24 . The proximal pair of GluN2B subunits have M2 helices that Letter reSeArCH protrude more deeply into the ion channel vestibule in comparison to the GluN1 subunits, and therefore the GluN2B N + 1 site asparagine residues are located at the same level as the GluN1 N-site asparagines, and their side chains form a narrow constriction, consistent with previous studies 23 (Fig. 3a) . When the channels of the NMDA receptor and the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor are superposed, the AMPA receptor GluA2 R607 (the Q/R site) colocalizes with the critical N-site asparagines (N612) of GluN2B (Fig. 3b, c) . As glutamine substitution in this position eliminates binding of MK-801 21 , we hypothesize that the longer side chains of R607 or Q607 and the proximal-pore loop of the AMPA receptor A/C pair sterically hinder MK-801 binding (Fig. 3b, c ). Sequence alignment also shows a disparity between the residues involved in MK-801 binding to the NMDA receptor and those at the equivalent positions in AMPA receptors (Fig. 3d) . These residues are critical for MK-801 binding, as demonstrated by alanine substitutions or AMPA-like leucine substitutions, which eliminate binding of the blocker to the NMDA receptor (Fig. 2f) . These structural and amino acid differences explain why MK-801 shows selectivity for NMDA receptors and why simple substitution of NMDA receptor residues into the corresponding positions does not confer MK-801 binding and blocking of the ion channel to AMPA receptors.
To further characterize the position of MK-801, we used 3-iodo MK-801 (MK-801-I) (Fig. 4a) , and showed that the halogenated analogue binds to the intact receptor with an inhibition constant (K i ) of 742 ± 1.3 nM (Fig. 4b) . Despite extensive crystallization trials, we were unable to crystallize the MK-801-I-∆ATD-receptor complex. However, we were able to co-crystallize MK-801-I with the ∆2 NMDA receptor; subsequent anomalous diffraction studies allowed us to confirm that MK-801 binds in a similar position as in the ∆ATD structure and to validate the placement of the ligand (Extended Data Table 1, data set 2; C2 space group). The anomalous difference Fourier maps show two prominent peaks in the channel vestibule (Fig. 4c, d ), which are related by the two-fold axis along the ion channel pore and situated 'above' the pore loops of GluN1 and GluN2B subunits. This pose is consistent with the conclusion that MK-801 resides in the channel vestibule in two equivalent orientations, with position 3 of the MK-801 ring system on either side of the two-fold axis (Fig. 4c, d ).
We performed atomic-level, long-timescale molecular dynamics simulations 25 to assess the binding position of MK-801 and its 3-iodo derivative. We began a simulation starting from the intact ∆2 NMDA receptor crystal structure inserted into a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) membrane, with MK-801-I placed in the central vestibule at a position suggested by the anomalous difference densities and by the MK-801-∆ATD receptor complex structure (Fig. 4 , simulation 1 in Supplementary Table 1) . During this 30-μs molecular dynamics simulation, we observed two predominant poses of MK-801-I, in overall agreement with the crystallographic results (Fig. 4d) . In both poses the amine group of the ligand points towards the selectivity filter, where it forms stable hydrogen bonds with the two pore-loop asparagine residues N614 (GluN1) and N612 (GluN2B) (Fig. 4d) .
To gain insight into the binding of MK-801 to the ion channel without starting from a pose derived from the crystal structure, we performed long-timescale simulations of 'free' MK-801 binding to a model of the open, activated state of the receptor. We obtained a model of the open state by computationally introducing two mutations, A650R (GluN1) and A648R (GluN2B), within the nine-residue SYTANLAAF 'lurcher' motif 26 . These mutations are known to increase the open probability of the wild-type receptor 27 , and led to the opening of the ion channel pore within a few microseconds (Fig. 4e , f, simulation 3), presumably owing to increased charge repulsion at the M3 bundle-crossing region. After observing that the resulting open, but still nonpermeating, mutant channel maintained hydration of its pore cavity on a microsecond timescale, we reversed the mutations and verified that the wild-type channel remained in a stable open and now conducting state, with an average conductance of 4.8 ± 1.4 pS (simulations 4-17). The experimental permeation rate is 51.4 ± 2.4 pS 28 ; this disagreement is unsurprising, as it is known that molecular dynamics simulations typically do not accurately reproduce experimental ion permeation rates Letter reSeArCH binding, the r.m.s.d. value drops, approaching the value obtained in our simulations of the closed-apo pore (simulation 2). Over the last part of each binding simulation (for example, the last 40 μs of simulation time in simulation 20, a 60-μs simulation), MK-801 predominantly assumed two distinct binding poses, similar to those found for MK-801-I in simulation 1, where the amine group of MK-801 formed stable hydrogen bonds with the two pore-loop asparagine residues (Fig. 4g, i) .
Upon comparison of the simulated MK-801-bound receptor with the experimental structure, we noticed that MK-801 in the crystal structure resides in an intermediate pose between the two predominant binding poses observed in the simulations, indicating that the electron density of MK-801 in the crystal structure is an average of two distinct poses that are related by two-fold symmetry (Fig. 4g, i) . Additional simulations with memantine (Fig. 4h , j, simulations 24-27), indicate that this compound binds at a location nearly identical to the binding location of MK-801. Rapid entry (mean binding time 0.14 ± 0.02 μs) was again followed by a hydrophobic collapse of residues around the blocker, giving rise to a closed-blocked state of the receptor (Extended Data Figs. 5b, 6c) . Memantine, however, predominantly assumes a single binding pose, perhaps owing to its pseudo-symmetrical structure (Fig. 4h, j) . We estimated the absolute free energy of binding to the ∆2 receptor, and found K d ≈ 7.6 μM for memantine and K d ≈ 0.08 μM for MK-801. This 100-fold difference in relative affinity is similar to that between the experimental affinities, 147.4 μM and 1.1 μM (Extended Data Fig. 7a) , noting that the errors in the free energies are substantial (Extended Data Fig. 7) . We speculate that the off-rate of memantine is approximately 100-fold faster than that of MK-801, because the on-rates and the experimental and computational binding constants are similar for both ligands. The faster off-rate of memantine is important for its clinical efficacy 30 . Both MK-801 and memantine readily entered and bound to the pore cavity regardless of voltage, but an applied voltage drove the blockers deeper into the selectivity filter, where they formed hydrogen bonds with the N + 1 asparagine residue (N613 of GluN2B) (Extended Data Fig. 8 ). This might explain the experimental observation that the presence of the N + 1 asparagine residue leads to voltage dependency of MK-801 and memantine binding.
We observed large fluctuations in the selectivity filter in these long-timescale simulations, both because of force-field deficiencies and, potentially, because our simulations begin with structures for which the experimental information in the selectivity filter is incomplete. We therefore investigated whether restraining the selectivity filter close to the crystal structure would affect the binding poses of MK-801 and memantine (Extended Data Fig. 9 ). We conclude that conformational distributions of the selectivity filter do not affect the overall pose or position of memantine and that it blocks the pore in predominantly one pose, whereas MK-801 blocks the pore in two symmetry-related poses, with the same key interactions between the selectivity filter and each pore blocker. Additional control simulations show that MK-801 also adopts these two symmetry-related binding poses in the absence of torsional corrections to the selectivity filter (see Methods and Extended Data Fig. 9 .)
The structure of the ∆ATD GluN1-GluN2B receptor shows how the absence of the ATDs allows the LBD layer to adopt a previously unseen conformation (Supplementary Video 1). This deletion enables formation of crystals that diffract to sufficiently high resolution to allow us to position the ion channel blocker MK-801 . MK-801 and memantine bind within the TMD vestibule and block ion conduction by physical occlusion of the permeation pathway and by promoting closure of the Letter reSeArCH ion channel gate at the M3-helix-bundle crossing, yielding a closedblocked state. MK-801 binds in two, two-fold-related poses whereas memantine binds in a single predominant pose. Our studies define the molecular basis for ion channel block by MK-801 and memantine and lay foundations for the development of small molecules with desirable interactions with the NMDA receptor, such as receptor-subunit selectivity and affinity.
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MEthodS
Receptor constructs. The construct of the ∆ATD NMDA receptor is derived from the previously reported Xenopus laevis GluN1-GluN2B NMDA receptor ∆2 construct 3 and cloned into pEG BacMam 31,32 for virus-mediated expression in suspension-adapted cells. Residues 23-393 were removed from GluN1, residues 1-399 were removed from GluN2B, and the human placental alkaline phosphatase signal sequence (MLGPCMLLLLLLLGLRLQLSLG) was added to the N terminus of the ∆ATD GluN2B subunit 33 . The ∆2 construct was used for co-crystallization with iodo-MK-801 (Sanofi) for the anomalous diffraction studies. The DEER construct was designed with alanine substitutions of the endogenous cysteines, GluN1(C457A) and GluN2B(C458A), and a single cysteine GluN2B(R739C) substitution. Expression and purification. HEK293S GnTI − cells 34 were transduced using P2 or P3 BacMam virus (titre > 3 × 10 6 plaque-forming units (p.f.u.)) when the cell density reached 3 × 10 6 cells/ml at a multiplicity of infection (MOI) of 1:1 (GluN1:GluN2B) and incubated at 37 °C. At 14 h post transduction, 10 mM sodium butyrate was added to the cultures and the cultures were incubated at 30 °C for another 46 h. Cells were harvested and collected by centrifugation at 6,200g for 20 min. Cells were disrupted by sonication (4 s on, 8 s off for 10 min, power level 6.5) in 150 mM NaCl, 20 mM Tris-HCl pH8.0, at a v/v ratio of 25 ml buffer per litre culture. The cell debris was removed by centrifugation at 6,000g for 20 min and the membrane was collected by ultracentrifugation at 125,000g for 1 h, at 4 °C. Membranes were homogenized in 150 mM NaCl, 20 mM Tris-HCl pH 8.0 and solubilized in a buffer containing 1% lauryl maltose neopentyl glycol (MNG-3; Anatrace NG310), 0.8 mM aprotinin, 2 mg/ml leupeptin, 2 mM pepstatin A, 1 mM phenylmethylsulfonyl fluoride, 1 mM glutamate, 1 mM glycine and 2 mM cholesteryl hemisuccinate (CHS, Anatrace CH210) for 2 h, with stirring at 4 °C. Insoluble material was removed by centrifugation at 125,000g. The supernatant was loaded onto a StrepTactin column (~1 ml resin per litre culture, IBA 2-4010-025) and eluted with buffer containing 5 mM desthiobiotin. The receptor was concentrated and the GFP, octa-histidine and StrepII tags were removed by treatment with 3 C protease at 1:20 ratio (w:w) in tandem with endoglycosidase H treatment for 8 h at 4 °C before size-exclusion chromatography (SEC). The concentrated GluN1-GluN2B receptor was loaded onto a Superose 6 16/300 column equilibrated with 400 mM NaCl, 20 mM MES pH 6.5, 1 mM dodecyl maltoside (C12M) and 0.2 mM CHS. Peak fractions were pooled and concentrated to 2 mg/ml. Crystallization and cryoprotection. Prior to crystallization, 10 mM 6-cyclohexylhexyl-β-d-maltoside (CYMAL-6, Anatrace C326LA), 10 mM glutamate, 10 mM glycine and 1 mM MK-801 were added to the GluN1-GluN2B protein, incubated on ice for 14-16 h and the protein solution was then centrifuged at 70,000g for 40 min at 4 °C. Crystals were grown by vapour diffusion using a reservoir solution composed of 100 mM MES pH6.5, 200 mM NaF and 19-20% polyethylene glycol 3350. Crystals were cryoprotected with mother liquor supplemented with 14% ethylene glycol. To obtain iodo-MK-801-complexed crystals, 1 mM iodo-MK801was co-crystallized with the protein in 18-20% pentaerythritol ethoxylate, 100 mM NaCl, 100 mM MgCl 2 and 100 mM MES pH 6.5. Crystals were cryoprotected with crystallization buffer supplemented with 12% ethylene glycol. All crystals were obtained by hanging drop vapour diffusion with a drop ratio of 1 or 2 μl protein to 1 μl reservoir solution at 20 °C. Structure determination and analysis. X-ray diffraction data sets were collected at the Advanced Light Source on beamlines 8.2.1 and 5.0.2 and the Advanced Photon Source (APS) on beamlines 24ID-E and 24ID-C. Diffraction images were indexed, integrated and scaled by XDS 35 or HKL2000, with the microdiffraction assembly method 36 . The best data set was collected at APS 24ID-E and the data extended to Bragg spacings at 3.9 Å, 3.7 Å and 3.4 Å resolution along a * , b * and c *37
. The structure was determined by molecular replacement with Phaser 38 . Model building and crystallographic refinement were carried out using the computer graphics program Coot 39 and the crystallographic refinement software package Phenix 40 . We were guided in building the ∆ATD TMD by referring to the intact receptor structure 3 , using aromatic side chains to define sequence register. The model was refined to a nominal resolution of 3.6 Å with reasonable R factors. Stereochemistry of the model was evaluated by MolProbity 41 and figures were created using Pymol. In analysing the tunnels of the transmembrane domain, because multiple side chain groups were truncated upon model building owing to insufficient electron density, we incorporated the side chains in order to analyse the path and radii of the tunnels. The side chains were built using SWISS-MODEL 42 and the tunnel size and radius were measured using CAVER 43 . Two-electrode voltage clamp. Recombinant NMDARs were expressed in Xenopus laevis oocytes after cytoplasmic injection of a 50-nl mixture of RNAs encoding the particular GluN1 and GluN2B subunits (at 500 ng/μl concentration, ratio 1:1) and stored at 16 °C in Barth's solution (in mM: 10 HEPES, pH 7.5, 88 NaCl, 2.4 NaHCO 3 , 1 KCl, 0.33 Ca(NO 3 ) 2 , 0.91 CaCl 2 , 0.82 MgSO 4 ) supplemented with 50 μM AP5 and 100 μg/ml gentamicin. Recordings were performed using a bath solution containing (in mM) 5 HEPES, pH 7.3, 100 NaCl, 2.8 KCl and 0.3 BaCl 2 . EDTA (10 μM final concentration) was added to all bath solutions. Currents were elicited by simultaneous application of 300 μM glycine and 300 μM glutamate. The holding potential was −60 mV. Ligand-binding assays. Binding constants were measured by the scintillation proximity assay (SPA) 44 . SPAs were set up in triplicate at a final volume of 100 μl in SPA buffer (20 mM Tris pH 8.0, 150 mM NaCl, 0.01% MNG-3 and 0.02 mM CHS). NMDA receptor (50 nM, purified from affinity chromatography) was incubated with 0.5 mg/ml Ysi-Cu SPA beads, [ 3 H]MK-801 and 1 mM each of glutamate and glycine. Non-specific binding was determined by the addition of 400 μM phencyclidine (PCP). Inhibition constants were determined by the SPA using 50 nM receptor, 0.5 mg/ml Ysi-Cu SPA beads, 2 μM [ 3 H]MK-801 and 1 mM each of glutamate and glycine and varying concentrations of 'cold' iodo-MK-801. The samples were gently mixed and incubated at room temperature for 2 h before the counts were measured. The counts were analysed using GraphPad Prism. Molecular dynamics simulations. All molecular dynamics simulations were based on the crystal structure of the ∆2 GluN1-GluN2B intact, heterotetrameric receptor (PDB code: 4TLM); GluN1: chains A and C; GluN2B: chains B and D). Missing loops (chain A: 547-549, 583-590, 650-653; chain B: 532-540, 576-584, 638-649, 789-797; chain C: 482-502, 540-550, 583-591, 786-796; chain D: 383-396, 434-445, 534-540, 789-793) were built using MOE 45 . Protonation states of all residues were chosen to correspond to a pH value of 7. The receptor was embedded in a POPC lipid bilayer hydrated by 0.2 M NaCl. The system contained ~507,000 atoms and measured ~160 × 160 × 188 Å 3 . To impose a transmembrane voltage difference, V, we applied constant electric fields of −0.0125 ≤ E ≤ −0.075 kcal mol
), corresponding to −100 ≤ V ≤ −600 mV 29, 46 . To study the binding of the endogenous ligand analogues 1AC (1-aminocyclopropane-1-carboxylic acid) and JEG (trans-1-aminocyclobutane-1,3-dicarboxylic acid), we simulated the LBD of the GluN1 subunit in isolation (simulations 34 and 35) and the LBD dimer (LBD1: residues 397-544, 661-789; LBD2: residues 399-534 and 647-785; simulations 36-40); both constructs were derived from simulation 2 of the intact heterotetrameric receptor. All simulations were performed in the NPT ensemble at 310 K using Anton 47 .
Simulations of receptor-bound, MK-801-I (simulation 1) were initiated with the ligand docked into the vestibule such that the ligand iodine atom initially occupied one of the two experimentally obtained anomalous difference densities (Fig. 4) . A control simulation (simulation 2) of the same system in the absence of MK-801 was performed for comparison and showed no notable differences with simulation 1 in either the pore vestibule or elsewhere in the receptor.
To simulate free binding of MK-801 to a model of the open-state receptor, we first performed a simulation (simulation 3) to open the closed pore by introducing two mutations, A650R (GluN1) and A648R (GluN2B), near the M3-helix-bundlecrossing region, within the nine-residue SYTANLAAF lurcher motif 26 . Such mutations are known to enhance the constitutive activity of the receptor 27 . Next we performed a series of simulations (simulations 4-17) in which we reversed the mutations and verified that the wild-type channel remained in a stable open and now conducting state. All of these simulations were performed at negative transmembrane voltage. Subsequently, simulations of free binding of MK-801 to the open pore were carried out on the back-mutated wild-type receptor with and without a negative voltage (simulations 18-23). To increase the ligand-binding on-rate, we imposed a spherical flat-bottom harmonic restraint between MK-801 and the receptor vestibule, centred at the midpoint of 642 (GluN1) and 640 (GluN2B) with a 30.0 Å radius. Finally, we performed a series of comparative simulations of free binding of memantine, a known NMDA receptor antagonist closely related to MK-801 (simulations 24-32).
In all simulations, harmonic restraints were imposed on the endogenous ligand analogues (4-[(1R,2S)-3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol (QEM), trans-1-aminocyclobutane-1,3-dicarboxylic acid (JEG) and 1-aminocyclopropanecarboxylic acid (1AC), which are present in the crystal structure) in order to prevent unbinding from their respective binding sites within the extracellular LBD. In separate simulations of the intact receptor (simulation 33), a single LBD (simulations 34 and 35) and the LBD dimer (simulations 36 and 40), all without ligand restraints, the two charged ligands (JEG and 1AC) consistently unbound too rapidly, with mean unbinding times of 0.4 ± 0.1 μs (JEG, n = 5) and 5.1 ± 1.9 μs (1AC, n = 7). The uncharged QEM did not unbind. An additional control simulation (simulation 41) of a crystal structure of the GluN1-GluN2A LBD dimer, co-crystallized with glutamate and glycine (PDB code: 5H8F 48 ), consistently resulted in excessively rapid unbinding of the charged ligand (glutamate).
Backbone torsional corrections to residues 614-618 (chains A and C) and 612-616 (chains B and D) (which lowered the backbone torsional potential by 4.6 kcal mol −1 at the crystallographic ϕ and ψ values, θ 0 , relative to the value of the potential at θ 0 + 180°) were applied to ensure that the conformation of the selectivity filter remained intact during the simulations. We imposed these Letter reSeArCH corrections because the free-energy minimum in the force field at the (correct) crystal structure is unfortunately too shallow to ensure structural integrity of the filter region on the simulation timescales reported here 29 . In a subset of the simulations, additional r.m.s.d. restraints were imposed on the selectivity filter residues to study the effect of restraints on the binding poses. We found that the resulting conformational distributions of the selectivity filter influenced some details of the pore-blocker binding poses. We also performed a set of 13 control simulations (simulations 42-54; lengths ranging from 10-30 μs) of the full-length ∆2 receptor without backbone torsional corrections and analysed the binding poses of MK-801-I and MK-801 before deterioration of the filter region. We found that the resulting binding poses were similar to those obtained in the simulations with the filter corrections (Extended Data Fig. 9) .
We used the CHARMM27 force field for the protein, ions and water 49, 50 , and the CHARMM36 force field for POPC 51 . Modified partial charges were used for Glu, Asp and Arg residues 52 . We used the CHARMM general force field 53, 54 for all ligands and reparameterized all partial charges and torsional angles.
The aggregate simulation time was ~900 μs and individual simulations ranged from 12 μs to 60 μs. Additional simulation details are given in Supplementary  Table 1 . Spin labelling and DEER experiments. The DEER construct was expressed in HEK293S GnTI − cells using the same protocol as for the ∆ATD receptor. The Strep-Tactin-purified GFP-fused protein was digested with 3 C protease at 4 °C when dialysed overnight against labelling buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.2, 0.1% MNG-3 and 0.2 mM CHS). The labelling reaction was started by adding a tenfold molar excess of 1-oxyl-2,2,5,5-tetramethylpyrroline-3-methylmethanethiosulfonate (MTSSL) and incubating the mixture at room temperature in the dark. After 1 h, another tenfold MTSSL was added and incubated for an additional 1 h. The protein was kept on ice overnight, followed by gel filtration the next day. Peak fractions were pooled and concentrated. Electron paramagnetic resonance (EPR) spectra were obtained using continuous wave EPR as described previously 55 . DEER experiments were performed using a standard four-pulse protocol 56 and the resulting signals were analysed assuming that the distance distributions, P(r), consist of a sum of Gaussians pose identification period, 9-12 μs; simulation 53: pose identification period, 3-4 μs). MK-801 bound stably to the receptor in three (simulations 50, 51 and 53) out of five simulations performed without correctionsagain in two distinct poses, as observed in our simulations with torsional corrections-and some closure of the activation gate (that is, the bundlecrossing region) was also observed in these three simulations before the filter deteriorated. 
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